Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|May 4, 2020

In an Instant: The Changing Face of Psychiatry

Author(s)P Priyanka, MD

FaceTime, Skype, and other video chat functions are the new normal in the COVID-19 era, and allow this community psychiatrist serve the underserved.

Medical Director for California-based Community Psychiatry, Dr Priyanka shares her experience with telepsychiatry and discusses the transformation of telemedicine before, during, and (hopefully) after COVID-19. Community Psychiatry is an outpatient psychiatric care company with over 120 clinicians in over 40 locations across California.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related to this article

stimulant use disorder

September 23rd, 2026

FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder

FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.

Trending on Psychiatric Times

ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials

Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment

From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry

Post Hoc SOLARIS Data Support Stabilization and Remission With Subcutaneous Olanzapine

Hippocampal Generative Processes During Sleep Support Rapid Learning of New Associations